Daddas Pharmalabs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 07-07-2024
- Paid Up Capital ₹ 0.10 M
as on 07-07-2024
- Company Age 3 Year, 11 Months
About Daddas Pharmalabs
The Company is engaged in the Environment Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bhavesh Gandhi and Harsh Shandilya serve as directors at the Company.
- CIN/LLPIN
U37100MH2020PTC352540
- Company No.
352540
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Dec 2020
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Daddas Pharmalabs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhavesh Gandhi  | Director | 25-Dec-2020 | Current |
| Harsh Shandilya | Director | 25-Dec-2020 | Current |
Financial Performance of Daddas Pharmalabs.
Enhance accessibility to Daddas Pharmalabs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Daddas Pharmalabs?
Unlock access to Daddas Pharmalabs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Tempo Instruments Private LimitedActive 16 years 3 monthsBhavesh Gandhi and Harsh Shandilya are mutual person
Top Syringe Manufacturing Company Private LimitedActive 13 years 9 monthsBhavesh Gandhi and Harsh Shandilya are mutual person
Sunderji Chatrabhuj Estates Private LimitedActive 14 years 9 monthsBhavesh Gandhi and Harsh Shandilya are mutual person
- Vivin Instruments Private LimitedActive 46 years 5 months
Bhavesh Gandhi and Harsh Shandilya are mutual person
- Daddas Medical Private LimitedActive 14 years 9 months
Bhavesh Gandhi and Harsh Shandilya are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Daddas Pharmalabs?
Daddas Pharmalabs has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Daddas Pharmalabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daddas Pharmalabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
